-
EP1865001
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1865001
| EP1865001 - Specific protease inhibitors and their use in cancer therapy [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.11.2008 Database last updated on 06.07.2024 | Most recent event Tooltip | 13.11.2008 | Application deemed to be withdrawn | published on 10.12.2008 [2008/50] | Applicant(s) | For all designated states GSF-FORSCHUNGSZENTRUM FÜR UMWELT UND GESUNDHEIT, GMBH Ingolstädter Landstrasse 1 85764 Neuherberg / DE | [2007/50] | Inventor(s) | 01 /
Maetzel, Dorothea St. Magnusstrasse 30 81545 München / DE | 02 /
Münz, Markus Kanalstrasse 16 82515 Wolfratshausen / DE | 03 /
Gires, Olivier Baaderstrasse 78 80469 München / DE | [2007/50] | Representative(s) | Bösl, Raphael Konrad Patentanwälte Isenbruck Bösl Hörschler PartG mbB Eastsite One Seckenheimer Landstraße 4 68163 Mannheim / DE | [N/P] |
| Former [2007/50] | Bösl, Raphael Konrad Patentanwälte Isenbruck Bösl Hörschler Wichmann Huhn Prinzregentenstrasse 68 81675 München / DE | Application number, filing date | 06011852.8 | 08.06.2006 | [2007/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1865001 | Date: | 12.12.2007 | Language: | EN | [2007/50] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 01.12.2006 | Classification | IPC: | C07K16/30, A61K39/395, C07K14/705, C12N9/50 | [2007/50] | CPC: |
C07K14/8107 (EP)
| Designated contracting states | [2008/34] |
| Former [2007/50] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | Spezifische Proteaseinhibitoren und ihre Verwendung in der Krebstherapie | [2007/50] | English: | Specific protease inhibitors and their use in cancer therapy | [2007/50] | French: | Inhibiteurs spécifiques de protéase et leur utilisation dans la thérapie de cancer | [2007/50] | Examination procedure | 13.06.2008 | Application deemed to be withdrawn, date of legal effect [2008/50] | 21.07.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2008/50] | Fees paid | Penalty fee | Additional fee for renewal fee | 30.06.2008 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO0044730 (AMERICAN CYANAMID CO [US]) [X] 13,14 * the whole document *; | [X]WO2005008250 (ANGIOGENETICS SWEDEN AB [SE], et al) [X] 13,14 * claims 1,2,4,6 *; | [A]WO2005080428 (MICROMET AG [DE], et al) [A] 1-12,14 * the whole document *; | [A] - LILJEFORS MARIA ET AL, "Anti-EpCAM monoclonal antibody (MAb17-1A) based treatment combined with alpha-interferon, 5-fluorouracil and granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma", INTERNATIONAL JOURNAL OF ONCOLOGY, (200409), vol. 25, no. 3, ISSN 1019-6439, pages 703 - 711, XP002407084 [A] 1-12,14 * the whole document * | [A] - ARMSTRONG ANDREW ET AL, "EpCAM: A new therapeutic target for an old cancer antigen.", CANCER BIOLOGY & THERAPY. 2003 JUL-AUG, (200307), vol. 2, no. 4, ISSN 1538-4047, pages 320 - 326, XP002407085 [A] 1-17 * the whole document * | [A] - MICHAEL BENK, "Untersuchungen zur Signaltransduktion des epithelialen Adhäsionsmoleküls EpCAM", DISSERTATION AN DER FAKULTÄT DER BIOLOGIE DER LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN, (200605), pages 1 - 92, XP002407086 [A] 1-17 * figure 4.3 * |